 Recent research suggests that erythropoietin, EPO, may be beneficial in treating acute kidney injury caused by gentamicin. Studies have found that EPO can reduce the severity of gentamicin-induced renal damage if administered either before or after gentamicin treatment. This suggests that EPO may be able to prevent or reverse the damage caused by gentamicin. Further research is needed to understand how this works and what other potential applications it may have. This article was authored by Mary Katka D.